GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

TCI · Dec 31, 2025

TRANSCONTINENTAL REALTY INVESTORS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000733590-26-000004Reit
Operating-cash-flow growth20thOwn-history percentile · N=10
Evidence method

Yoy · gp.fundamentals.operating_cash_flow

-320.31% · OPTIONAL · VALID

Debt80thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_debt

$210.8M · CORE · VALID

Net-income growth75thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

135.47% · CORE · VALID

Revenue growth70thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

4.23% · CORE · VALID

Cash and equivalents15thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$14.1M · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History28 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-40.40%
Current
-320.31%
Delta
-279.91%
Debt Decreased
Previous
$223.5M
Current
$210.8M
Delta
-$12.7M
Earnings Growth Increased
Previous
-57.59%
Current
135.47%
Delta
193.05%
Growth Decreased
Previous
10.58%
Current
4.23%
Delta
-6.35%
Liquidity Increased
Previous
$11.9M
Current
$14.1M
Delta
$2.2M
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.